Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ephedrine combinations for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy
IRCT20191104045328N34Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Ephedrine + distilled water, Ephedrine + chlorpheniramine and Ephedrine + haloperidol (3 arms). Primary endpoints: Ramsey score, Severity of nausea and vomiting and 3 more. Started May 2025; status: completed.
02
Drugs
ephedrinechlorpheniraminehaloperidol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20191104045328N34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N34.